Close Menu

CPTAC

The sites will collect primary human tumors according to a protocol optimized for proteomics for the NCI's Clinical Proteomic Tumor Analysis Consortium.

The core will serve as a center for receiving, qualifying, processing, and distributing biospecimens to the Clinical Proteomic Tumor Analysis Consortium.

Researchers working onbreast, colorectal, and ovarian cancer highlighted their work, making the case for proteogenomic approaches to cancer research.

The project aims to develop multiple-reaction monitoring mass spec and immuno-MRM mass spec assays for roughly 100 proteins involved in RAS signaling.

From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.

NEW YORK (GenomeWeb) – An international research team has completed a multi-omic pan-cancer analysis of data on 3,527 tumors spanning 12 different cancer types generated by the National Cancer Institute's Cancer Genome Atlas consortium.

CPTAC Launches MRM Assay Portal

Premium

NEW YORK (GenomeWeb) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium has launched an assay portal for multiple-reaction monitoring mass spec assays.

NEW YORK (GenomeWeb) – Researchers from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium have completed a proteogenomics analysis of human colon and rectal cancer tumors.

NEW YORK (GenomeWeb News) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium this week released a comprehensive dataset of proteomic analyses of 174 high grade serous ovarian tumor samples previously analyzed by The Cancer Genome Atlas initiative.

Researchers at Utrecht University have completed a proteogenomics study of rat liver tissue, integrating whole genome sequencing, RNA-seq, and mass spec-based proteomics.

Pages

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.